The Swiss pharmaceutical industry is the driver of exports for Switzerland’s economy. Even though the markets of the BRIC countries and the US have grown in the last few years, Europa remains by far the most important destination for the export of pharmaceutical products from Switzerland. If the pharmaceutical industry in Switzerland is to remain healthy and continue with its remarkable contribution to the economy in the future, it is dependent on good political framework conditions. These include the absolutely key issue of reasonable and stable relations with Europe. For this reason, the pharmaceutical industry and research in Switzerland set great store by a constructive policy on Europe. The new brochure explains why good trade relations are important and why specialists from both home and abroad are needed, addresses the importance of the bilateral accords, shows why trade barriers are harmful and explains the relevance of Horizon 2020 for Switzerland as a centre for research.